A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects

Clinical trial NCT01815684 · COMPLETED

Trial details

NCT number: NCT01815684
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Pharmacodynamics Healthy Subjects Safety

Start date: 2012-08-01
Primary completion: 2012-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.